CervoMed Inc. (CRVO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 3.5M 7M 10.5M Q3 '24: 10.1M Q4 '24: 9.7M Q1 '25: 9.3M Q2 '25: 7.8M Q3 '25: 6.2M Q4 '25: 4M Q1 '26: 2.1M Q2 '26: 331.3K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q2 '12: -1.7M Q3 '12: -1.5M Q4 '12: 216K Q1 '13: 285K Q2 '13: 214.2K Q3 '13: 71.7K Q4 '13: 71.7K Q1 '14: 71.7K Q2 '12 Q3 '12 Q4 '12 Q1 '13 Q2 '13 Q3 '13 Q4 '13 Q1 '14

Operating Income TTM

-45M -30M -15M 0 15M 30M 45M Q3 '24: -13.5M Q4 '24: -18.2M Q1 '25: -20.9M Q2 '25: -24.6M Q3 '25: -27.2M Q4 '25: -28.3M Q1 '26: -31.1M Q2 '26: -31.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-45M -30M -15M 0 15M 30M 45M Q3 '24: -11.9M Q4 '24: -16.3M Q1 '25: -18.7M Q2 '25: -22.6M Q3 '25: -25.6M Q4 '25: -27M Q1 '26: -30M Q2 '26: -30.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 900K 1.8M 2.7M Q2 '12: 2.5M Q3 '12: 2.3M Q4 '12: 230.2K Q1 '13: 1.7K Q2 '13: 850 Q3 '13: 0 Q4 '13: 0 Q1 '14: 0 Q2 '12 Q3 '12 Q4 '12 Q1 '13 Q2 '13 Q3 '13 Q4 '13 Q1 '14

Operating Cash Flow TTM

-30M -20M -10M 0 10M 20M 30M Q3 '24: -11M Q4 '24: -16.5M Q1 '25: -19M Q2 '25: -23.3M Q3 '25: -24.9M Q4 '25: -23.4M Q1 '26: -27.6M Q2 '26: -28M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-15M -10M -5M 0 5M 10M 15M Q1 '16: -8.9M Q2 '16: -10.8M Q3 '16: -11.6M Q4 '16: -10.8M Q1 '17: -9.6M Q2 '17: -9.5M Q3 '17: -11.9M Q4 '17: -12.8M Q1 '16 Q2 '16 Q3 '16 Q4 '16 Q1 '17 Q2 '17 Q3 '17 Q4 '17

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 3.5M 7M 10.5M Q1 '24: 6.2M Q2 '24: 8.7M Q3 '24: 8.7M Q1 '25: 8.7M Q2 '25: 9M Q3 '25: 9.3M Q1 '26: 9.3M Q2 '26: 10.2M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '24: 2.43 Q4 '24: -2.03 Q1 '25: -2.18 Q2 '25: -2.61 Q3 '25: -2.90 Q4 '25: -2.98 Q1 '26: -3.28 Q2 '26: -3.22 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.